The United States Center for Disease Control, and Prevention and the US Food and Drug Administration have recommended that the country suspend the use of Johnson & Johnson’s Covid-19 vaccine, following the report of over six cases of a “rare and severe” type of blood clot.
This six cases occurred among women aged 18 and 48, and symptoms occurred six to 13 days after vaccination, Anne Schuchat, Principal Deputy Director of the CDC and Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research revealed in a joint statement on Tuesday.
More than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the United States so far, including the six cases of blood clot.
In a statement, the CDC said, it will arrange a meeting of the Advisory Committee on Immunization Practices, ACIP, on Wednesday to further review these cases and measure their potential consequence.
